Koenig U D
Arch Gynecol. 1978 Dec 29;226(4):315-24. doi: 10.1007/BF02119222.
Cellular mediated immune reactions (CMI) against tumour associated antigens are the demonstration of an interrelationship between tumour and tumour host. They are related to the stage and prognosis of the disease. 41 patients with cervical cancer were tested by leukocyte-migration-inhibition test. Cryostat sections of 10 micron of the tumour-tissue, gained by excision or curettage and histologically defined, were taken as tumour antigens. The test was performed in Sykes-Moore-Chamber as so-called one-way-test with the lymphocytes/leukocytes and macrophagen of the tumour patient. Reactions against autologous and homologous tumour tissue and against recall antigens (tuberculin and varidase) were tested. There was no overall diminution of cellular mediated immune reactions. CMI was demonstrated in 69.7% (inhibition in 30.3%, stimulation in 39.4%) in the autologous and in 51.3% in the homologous system (21.6% inhibition, 29.7% stimulation).
针对肿瘤相关抗原的细胞介导免疫反应(CMI)体现了肿瘤与肿瘤宿主之间的相互关系。它们与疾病的分期和预后相关。对41例宫颈癌患者进行了白细胞移动抑制试验。通过切除或刮除获取的、经组织学界定的10微米肿瘤组织冰冻切片被用作肿瘤抗原。该试验在赛克斯 - 摩尔小室中进行,作为针对肿瘤患者淋巴细胞/白细胞和巨噬细胞的所谓单向试验。检测了针对自体和同源肿瘤组织以及针对回忆抗原(结核菌素和链激酶)的反应。细胞介导免疫反应并没有整体减弱。在自体系统中,69.7%的患者表现出CMI(30.3%为抑制,39.4%为刺激),在同源系统中为51.3%(21.6%为抑制,29.7%为刺激)。